Sale!

PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test” is a specialized diagnostic procedure aimed at identifying mutations in the PIGN gene, which is known to cause Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 (MCAHS1). MCAHS1 is a rare genetic disorder characterized by a combination of birth defects, muscle weakness (hypotonia), and seizures, among other symptoms. The test is crucial for confirming a diagnosis, understanding the condition’s severity, guiding treatment decisions, and providing information for genetic counseling.

This genetic test is conducted at DNA Labs UAE, a facility renowned for its state-of-the-art genetic testing services. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the genetic alterations within the PIGN gene. By opting for this test at DNA Labs UAE, patients and their families can expect reliable results, which are essential for managing the syndrome effectively and planning for the future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test

Are you looking for a genetic test to diagnose Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 (MCAHS1)? DNA Labs UAE offers the PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test.

Test Details

The PIGN gene is associated with a rare genetic disorder called Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 (MCAHS1). This syndrome is characterized by a combination of birth defects, low muscle tone (hypotonia), and seizures.

NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MCAHS1, NGS Genetic Testing can be used to identify mutations or variations in the PIGN gene that may be responsible for the syndrome.

By analyzing the patient’s DNA, NGS Genetic Testing can provide valuable information about the presence of specific genetic changes in the PIGN gene. This can help in confirming a diagnosis, predicting disease progression, and informing appropriate treatment and management strategies for individuals with MCAHS1.

It is important to note that NGS Genetic Testing may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Additionally, genetic counseling is often recommended before and after genetic testing to discuss the potential benefits, limitations, and implications of the test results.

Test Name: PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 NGS Genetic DNA Test gene PIGN.

Test Name PIGN Gene Multiple congenital anomalies-hypotonia-seizures syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PIGN Gene Multiple congenital anomalies-hypotonia-seizures syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PIGN Gene Multiple congenital anomalies-hypotonia-seizures syndrome type 1 NGS Genetic DNA Test gene PIGN
Test Details

The PIGN gene is associated with a rare genetic disorder called Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 (MCAHS1). This syndrome is characterized by a combination of birth defects, low muscle tone (hypotonia), and seizures.

NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MCAHS1, NGS Genetic Testing can be used to identify mutations or variations in the PIGN gene that may be responsible for the syndrome.

By analyzing the patient’s DNA, NGS Genetic Testing can provide valuable information about the presence of specific genetic changes in the PIGN gene. This can help in confirming a diagnosis, predicting disease progression, and informing appropriate treatment and management strategies for individuals with MCAHS1.

It is important to note that NGS Genetic Testing may not be available in all healthcare settings and may require a referral to a specialized genetic testing laboratory. Additionally, genetic counseling is often recommended before and after genetic testing to discuss the potential benefits, limitations, and implications of the test results.